Sidenafil protocols for the treatment of ICC: A literature review

Autores/as

  • Jaci Lopes da Silva
  • Rodrigo Lopes da Silva
  • Matheus Carvalho Siqueira Miranda

DOI:

https://doi.org/10.56238/isevjhv2n2-014

Palabras clave:

Sidenafil, Heart failure, Dysfunction, Angina, Erection, Viagra

Resumen

A literature search was conducted on the effects of sidenafil and the protocols used in heart failure. The phosphodiesterase-5 inhibitor stands out as a new drug in the cardiologic therapeutic arsenal, since the action of inhibiting the various types of phosphodiesterase causes an increase in cAMP and cGMP in white tissues.


DOI:https://doi.org/10.56238/isevjhv2n2-014

Descargas

Archivos adicionales

Publicado

2023-06-21

Número

Vol. 2 Núm. 2 (2023): March/April- 2023

Sección

Articles

Cómo citar

Sidenafil protocols for the treatment of ICC: A literature review. (2023). International Seven Journal of Health Research, 2(2), 235-243. https://doi.org/10.56238/isevjhv2n2-014